Search Results - "Cauda R"

Evolution of major non‐HIV‐related comorbidities in HIV‐infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014.

Authors: Castelli, F Cauda, R. Perri, G. et al.

Source: HIV Medicine. Feb2019, Vol. 20 Issue 2, p99-109. 11p.

RESEARCH NOTE Hospital infection control in Europe: evaluation of present practice and future goals.

Authors: Daschner, F. D. Cauda, R. Grundmann, H. et al.

Source: Clinical Microbiology & Infection. Mar2004, Vol. 10 Issue 3, p263-266. 4p.

New insights concerning methicillin-resistant Staphylococcus aureus disease.

Authors: .Cauda, R Garau, J.

Source: Clinical Microbiology & Infection. Feb2009, Vol. 15 Issue 2, p109-111. 3p.

Activation-associated mitochondrial hyperpolarization hijacks T cells toward an apoptosis-sensitized phenotype.

Authors: Matarrese, P Cauda, R Malorni, W

Source: Cell Death & Differentiation. May2003, Vol. 10 Issue 5, p609. 3p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Safety and effectiveness of switch to bictegravir/emtricitabine/tenofovir alafenamide following dual regimen therapy in people with HIV: Insights from the Icona cohort.

Authors: De Vito, Andrea Tavelli, Alessandro Cozzi‐Lepri, Alessandro et al.

Source: HIV Medicine. Jun2025, Vol. 26 Issue 6, p970-977. 8p.

The impact of DAA‐mediated HCV eradication on CD4⁺ and CD8⁺ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort.

Authors: Bandera, Alessandra Lorenzini, Patrizia Taramasso, Lucia et al.

Source: Journal of Viral Hepatitis. May2021, Vol. 28 Issue 5, p779-786. 8p.

Prevalence of Sexually Transmitted Infections and Factors Associated with HIV Status Among Vulnerable Women in Northern Uganda: Baseline Results from Pe Atye Kena Cohort Study.

Authors: Segala, F. V. Micheli, G. Seguiti, C. et al.

Source: Mediterranean Journal of Hematology & Infectious Diseases. 2021, Vol. 13 Issue 1, p1-8. 8p.

Lamivudine‐based maintenance antiretroviral therapies in patients living with HIV‐1 with suppressed HIV RNA: derivation of a predictive score for virological failure.

Authors: Borghetti, A Moschese, D Cingolani, A et al.

Source: HIV Medicine. Oct2019, Vol. 20 Issue 9, p624-627. 4p.

Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort.

Authors: Mondi, Annalisa Cozzi‐Lepri, Alessandro Tavelli, Alessandro et al.

Source: Journal of the International AIDS Society. Jan2019, Vol. 22 Issue 1, p1-10. 10p. 3 Charts, 1 Graph.

Immune response to rabbit liver-specific lipoprotein in acute viral hepatitis.

Authors: Ortona, L. Laghi, V. Cauda, R. et al.

Source: Clinical & Experimental Immunology. Dec1980, Vol. 42 Issue 3, p436-440. 5p.

Lymphocyte transformation test with rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.

Authors: Ortona, L. Laghi, V. Cauda, R. et al.

Source: Clinical & Experimental Immunology. Nov1979, Vol. 38 Issue 2, p231-234. 4p.

Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study.

Authors: Giannella, M. Trecarichi, E. M. De Rosa, F. G. et al.

Source: Clinical Microbiology & Infection. Dec2014, Vol. 20 Issue 12, p1357-1362. 6p.

Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients.

Authors: Fabbiani, M Ciccarelli, N Tana, M et al.

Source: HIV Medicine. Mar2013, Vol. 14 Issue 3, p136-144. 9p. 3 Charts, 1 Graph.

Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia.

Authors: Bassetti, M. Trecarichi, E. M. Mesini, A. et al.

Source: Clinical Microbiology & Infection. Sep2012, Vol. 18 Issue 9, p862-869. 8p.

Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010.

Authors: Colafigli, M. Torti, C. Trecarichi, E. M. et al.

Source: Clinical Microbiology & Infection. Aug2012, Vol. 18 Issue 8, pE299-E304. 6p.

Exposure to HIV-protease inhibitors selects for increased expression of P-glycoprotein (ABCB1) in Kaposi's sarcoma cells.

Authors: Lucia, M. B. Anu, R. Handley, M. et al.

Source: British Journal of Cancer. 8/9/2011, Vol. 105 Issue 4, p513-522. 10p. 2 Charts, 4 Graphs.

Mid-dosing interval concentration of atazanavir and virological outcome in patients treated for HIV-1 infection.

Authors: Fabbiani, M. Di Giambenedetto, S. Ragazzoni, E. et al.

Source: HIV Medicine. May2010, Vol. 11 Issue 5, p326-333. 8p. 3 Charts, 2 Graphs.

Long-term follow-up of nevirapine-treated patients in a single-centre cohort.

Authors: Colafigli, M. Di Giambenedetto, S. Bracciale, L. et al.

Source: HIV Medicine. Sep2009, Vol. 10 Issue 8, p461-469. 9p. 3 Charts, 2 Graphs.